-P Robbins Researcher Activity Profile

Research Author Detailed Information 

P Robbins Publication Rate By Year

P Robbins has published 1 paper(s) in 2000, 2 paper(s) in 2001, 1 paper(s) in 2002, 1 paper(s) in 2003, 2 paper(s) in 2004, 3 paper(s) in 2005, 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 15 research publications in total.

P P Robbins Author Information

LAST NAME: robbins

FIRST NAME: P

INITIALS: p

AFFILIATION:

Papers

P Robbins's Publication Record

1. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. Year Published: 2000
Growth and Development Laboratory, Department of Orthopaedic Surgery, Children's Hospital and University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
2. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. Year Published: 2001
Children's Hospital of Pittsburgh, Pennsylvania 15261, USA.
3. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. Year Published: 2001
Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15213, USA. niyi@pitt.edu
4. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Year Published: 2002
Growth and Development Laboratory, Department of Orthopaedic Surgery, Children's Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, PA 15260, USA.
5. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Year Published: 2003
Ferguson Laboratory for Orthopaedic Research, Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
6. Paradoxical embolism secondary to ovarian carcinoma resulting in stroke. Year Published: 2004
Departments of Neurosurgery, Sir Charles Gairdner Hospital and Pathcentre, QE II Medical Centre, Australia. bassmana@iinet.net.au
7. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Year Published: 2005
Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
8. [Refined adenoviral transduction for controlled gene transfer into human adult mesenchymal stem cells] Year Published: 2005
9. [Osteoblastic differentiation of human adult mesenchymal stem cells after through gene transfer of BMP-2 in the absence of dexamethasone] Year Published: 2005
10. Pr40p metastatic chondroid syringoma. Year Published: 2007
University of Western Australia, Western Australia, Australia.
11. A case of giant ecchordosis physaliphora: a case report and literature review. Year Published: 2007
Department of Otolaryngology and Head and Neck Surgery, Sir Charles Gairdner Hospital, Western Australia, Australia. shanus@iinet.net.au
12. Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. Year Published: 2007
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
13. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. Year Published: 2008
Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, Biometrics Research Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892-1184, USA.
14. Paradoxical embolism secondary to ovarian carcinoma resulting in stroke. Year Published: 2004
Departments of Neurosurgery, Sir Charles Gairdner Hospital and Pathcentre, QE II Medical Centre, Australia. bassmana@iinet.net.au
15. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. Year Published: 2008
Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, Biometrics Research Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892-1184, USA.